United States News Todas as matérias

Fastenal (NASDAQ:FAST) reported third-quarter 2026 financial results, delivering higher-than-expected revenue and earnings.

Bank of America (NYSE:BAC) reported third-quarter 2026 financial results with adjusted earnings per share of $1.08, compared with analyst expectations of $1.10.

National Fuel Gas (NYSE:NFG) announced that its board of directors approved a plan to spin off its Integrated Upstream and Gathering (IUG) business into a separate public company.

Quoin Pharmaceuticals (NASDAQ:QNRX) announced that the European Medicines Agency has granted orphan drug designation to QRX003 for the treatment of Peeling Skin Syndrome, a rare genetic skin disorder.

Ocugen (NASDAQ:OCGN) entered an agreement granting Roots Pharmaceutical exclusive regional rights to OCU400, an investigational gene therapy for retinitis pigmentosa, an inherited vision-loss disease.

BlackRock (NYSE:BLK) reported third-quarter 2026 financial results with revenue of $7.8 billion, representing a 19% increase compared with the same period last year.

Verastem Oncology (NASDAQ:VSTM) reported updated Phase 1/2 TARGET-D 101 trial results for VS-7375, an investigational oral KRAS G12D inhibitor, across multiple KRAS G12D-mutated solid tumors.

Yiren Digital (NYSE:YRD) reaffirmed its intention to continue implementing its previously announced share repurchase program of up to US$20 million.

High Templar Tech (NYSE:HTT) reported first-half 2026 shareholder net income of RMB416.9 million, compared with RMB461.9 million in the same period last year.

Oil prices moved higher after vessels were struck in the Strait of Hormuz and Iranian officials said new tactics were being used to target ships in the region.

Rhythm Pharmaceuticals (NASDAQ:RYTM) commercially launched IMCIVREE (setmelanotide) in Japan for patients with acquired hypothalamic obesity following its inclusion on the national insurance price list.

Alvotech (NASDAQ:ALVO) and Advanz Pharma submitted a regulatory application in Europe for AVT29, a proposed biosimilar referencing Eylea 8 mg, a treatment used for retinal diseases.

ASML (NASDAQ:ASML) reported third-quarter 2026 results with net sales of €11.7 billion, compared with higher profitability in the previous quarter due to improved gross margin and net income.

Danaher (NYSE:DHR) announced a collaboration with NVIDIA (NASDAQ:NVDA) to combine its scientific instruments and laboratory processes with artificial intelligence technologies.

Liberty Global (NASDAQ:LBTYA) received EU Commission approval for the sale of VodafoneZiggo’s passive tower assets to infrastructure investors for €669 million.

NVIDIA (NASDAQ:NVDA) committed $250 million in computing access to support U.K. researchers studying the safety and security of artificial intelligence agents.

Leidos (NYSE:LDOS) received a one-year extension for the Logistics Commodities and Services Transformation (LCST) contract, continuing its end-to-end logistics support for the UK Armed Forces.

Pharming (NASDAQ:PHAR) presented Phase II topline results from a study evaluating leniolisib in patients with genetically identifiable primary immunodeficiencies involving immune dysregulation beyond activated PI3K delta syndrome (APDS).

Goldman Sachs (NYSE:GS) reported third-quarter 2026 results with net revenue of $18.68 billion, up from analyst estimates of approximately $16.71 billion to $16.86 billion.

BetMGM, jointly owned by MGM Resorts International (NYSE:MGM) and Entain, reported third-quarter 2026 net revenue of $710 million, representing a 7% increase compared with the same period last year.

Wells Fargo (NYSE:WFC) reported third-quarter 2026 results with net income of approximately $6 billion, up 13% year over year, and diluted earnings per share of $1.87.

SSR Mining (NASDAQ:SSRM) entered a definitive agreement to acquire all outstanding shares of Roxmore Resources (TSX:RM) through a court-approved plan of arrangement, adding the Converse Gold Project to its Nevada operations.

FB Financial Corporation (NYSE:FBK), the parent company of FirstBank, reported third-quarter 2026 net income of $60.2 million, or $1.20 per diluted common share, compared with $1.13 in the previous quarter and $0.43 in the third quarter of 2025.

Accenture (NYSE:ACN) announced the acquisition of Sagacity, a London-based data and customer intelligence company founded in 2005, to strengthen Accenture Song’s customer reinvention services.